Tropoelastin Self-Assembly Without Cross-Linking Agents

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for producing elastin using recombinant tropoelastin are limited by the need for cross-linking agents, which can be toxic and restrict the range of elastic properties, and pose challenges for delivery via standard administration routes like injection, as they can cause unwanted tissue reactions and limit the range of elastic properties that can be achieved.

Innovation Solution

A process involving heating a solution of tropoelastin at an alkaline pH, with a salt concentration of at least 25 mM and a temperature of about 37°C, to form an elastic material without the need for cross-linking agents, allowing for the creation of elastic materials with unique properties suitable for tissue repair and medical devices.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Strength

If cross-linking agents such as glutaraldehyde are used to produce elastin from recombinant tropoelastin, then the elastic material can be formed with desired elastic properties, but the cross-linking agents may be toxic and cause unwanted tissue reactions or allergy

Engineering Contradiction:
Improveelastic propertiesVSAvoidtoxicity and tissue reactions
Core Design Contradiction:
StrengthVSObject-affected harmful factors

Solution Approach 1:

The patent removes the harmful cross-linking agent (glutaraldehyde) from the system and replaces it with a physical method involving alkaline pH and heat treatment. This extraction of the toxic substance eliminates the harmful effects while maintaining the desired elastic material formation through alternative means.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent changes the formation parameters from chemical cross-linking to physical parameters (pH and temperature). By adjusting the pH to alkaline levels and applying heat, the tropoelastin molecules self-assemble into elastic materials without requiring toxic cross-linking agents, thus resolving the contradiction between achieving elastic properties and avoiding toxicity.

Inventive Principle:
Principle #35Parameter changes

2Adaptability or versatility

If cross-linking agents are used to form elastin, then the elastic properties can be controlled, but the range of elastic properties is limited and the cross-linking agent may cause the elastin to form prior to delivery to the site

Engineering Contradiction:
Improverange of elastic propertiesVSAvoiddelivery via injection
Core Design Contradiction:
Adaptability or versatilityVSEase of operation

Solution Approach 1:

The patent makes the formation process dynamic and controllable by using pH and temperature as可调 parameters. The elastic material forms only under specific conditions (alkaline pH and heat) after delivery, allowing flexible control over when and where the material transforms, thereby improving both the range of properties and ease of delivery.

Inventive Principle:
Principle #15Dynamics

Solution Approach 2:

The patent prepares the tropoelastin solution in a stable, non-gelling state for easy delivery, then triggers the formation of the elastic material only after delivery to the target site through pH and heat activation. This preliminary preparation avoids premature formation while maintaining deliverability.

Inventive Principle:
Principle #10Preliminary action

3Reliability

If cross-linking is used to produce elastin, then the material can be formed with desired properties, but the requirement for cross-linking precludes effective delivery via standard administration routes

Engineering Contradiction:
Improveelastin formationVSAvoiddelivery via injection
Core Design Contradiction:
ReliabilityVSEase of operation

Solution Approach 1:

The patent removes the cross-linking requirement from the system, allowing tropoelastin to be delivered via standard injection routes in a stable solution form. The elastic material forms only after delivery through pH and heat activation, resolving the contradiction between reliable formation and ease of delivery.

Inventive Principle:
Principle #2Taking out (Extraction)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enables the production of bio-compatible elastic materials that can be formed in situ, providing enhanced tensile and extensile strength, recoil, and biodegradability, facilitating effective tissue repair and medical device applications without the risks associated with cross-linking agents.

Implementation Method 1

heating a solution of tropoelastin having an alkaline pH to form an elastic material from the tropoelastin in the solution

Methodology Applied
Scientific EffectSelf-assembly: Self-Assembly

Implementation Method 2

heating a solution of tropoelastin having an alkaline pH and a temperature of about 37° C. to form an elastic material

Methodology Applied
Scientific EffectThermal energy: Heating

Data Source

PatentUS8101717B2Use of tropoelastin for repair or restoration of tissue
Publication Date: 2012.01.24 ALLERGAN PHARMACEUTICALS INTERNATIONAL LTD
  • US8101717B2 patent drawing

AI summary

The present invention relates to tropoelastin and to tissue repair and restoration using elastic materials. Disclosed is a process for producing an elastic material from tropoelastin including heating a solution of tropoelastin having an alkaline pH to form an elastic material from the tropoelastin in the solution. Also disclosed are elastic materials prepared according to this process and their applications.